Compare Neurocrine Biosciences Inc (NBIX) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Under Armour Inc Class A — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Under Armour Inc Class A trades at $7.18 (market cap $3.07B). The key difference: Neurocrine Biosciences Inc is far larger — about 5.7× Under Armour Inc Class A's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| NBIX | UA | |
|---|---|---|
Market Cap | $17.40B | $3.07B |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $7.88 |
52-Week Low | $123.10 | $3.96 |
Enterprise Value | $16.49B | $4.70B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
